NasdaqGS - Delayed Quote • USD
Azenta, Inc. (AZTA)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 4:02 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | 0.08 | 0.16 | 0.31 | 0.49 |
Low Estimate | 0.03 | 0.15 | 0.26 | 0.36 |
High Estimate | 0.14 | 0.18 | 0.38 | 0.6 |
Year Ago EPS | 0.13 | 0.13 | 0.31 | 0.31 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | 165.92M | 183.39M | 662.84M | 713.05M |
Low Estimate | 165.2M | 179.6M | 659M | 705.53M |
High Estimate | 166.18M | 185.29M | 665M | 722M |
Year Ago Sales | -- | 172.36M | 665.07M | 662.84M |
Sales Growth (year/est) | -- | 6.40% | -0.30% | 7.60% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
---|---|---|---|---|
EPS Est. | -0.02 | 0.02 | -0.03 | 0.02 |
EPS Actual | 0.13 | 0.13 | 0.02 | 0.05 |
Difference | 0.15 | 0.11 | 0.05 | 0.03 |
Surprise % | 750.00% | 550.00% | 166.70% | 150.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.08 | 0.16 | 0.31 | 0.49 |
7 Days Ago | 0.08 | 0.16 | 0.3 | 0.5 |
30 Days Ago | 0.09 | 0.14 | 0.26 | 0.53 |
60 Days Ago | 0.09 | 0.14 | 0.26 | 0.47 |
90 Days Ago | 0.09 | 0.14 | 0.26 | 0.46 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | 1 | -- |
Up Last 30 Days | 2 | 5 | 6 | 3 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | -- | -- | 1 |
Growth Estimates
CURRENCY IN USD | AZTA | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -38.50% | -- | -- | 8.00% |
Next Qtr. | 23.10% | -- | -- | 12.40% |
Current Year | 0.00% | -- | -- | 5.60% |
Next Year | 58.10% | -- | -- | 13.00% |
Next 5 Years (per annum) | 12.00% | -- | -- | 11.14% |
Past 5 Years (per annum) | -28.62% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Needham: Buy to Buy | 5/9/2024 |
Maintains | Needham: Buy to Buy | 4/8/2024 |
Maintains | Evercore ISI Group: In-Line to In-Line | 4/4/2024 |
Initiated | Jefferies: Hold | 4/4/2024 |
Reiterates | Needham: Buy to Buy | 3/28/2024 |
Maintains | Needham: Buy to Buy | 3/14/2024 |
Related Tickers
ANIK Anika Therapeutics, Inc.
25.40
-0.39%
ATRI Atrion Corporation
465.25
+2.06%
TECN.SW Tecan Group AG
333.20
-2.91%
ANGO AngioDynamics, Inc.
6.04
-5.92%
CTEC.L ConvaTec Group PLC
254.60
-0.31%
HBIO Harvard Bioscience, Inc.
3.3700
-2.03%
MMSI Merit Medical Systems, Inc.
81.89
-0.45%
HAZ.DU Haemonetics Corp
86.00
+1.18%
CBH.DU Coloplast A/S
11.30
+0.89%
ADDLF AddLife AB (publ)
7.94
-77.50%